Inspired by the viral TikTok trend of the 'everything shower', Space NK's latest collection includes all the bath products you need for a soothing, self-care evening at home. Featuring £165 worth ...

Roughly $11.1 trillion has been wiped away from the U.S. stock market since Jan. 17, the Friday before President Donald Trump took the oath of office and began his second term, according to data ...

Wed, April 9, 2025 at 5:13 PM UTC P!nk has been on a live concert roll and became one of the biggest touring acts of 2024. Since her album released, she played more than 128 shows over the last ...

Defense lawyer for Aaron Thomas cross examines state's first witness Witness gives different version of events during "puberty test" with Aaron Thomas SOUTH KINGSTOWN – A lawyer for Aaron Thomas ...

Amira El-Fekki is a Newsweek reporter based in Dubai. Her focus is reporting on politics and society in the Middle East. She has in depth knowledge of Arab communities and has covered human rights ...

More than four years after he stabbed his colleague, plastic surgeon Jonathan Peter Brooks has been found guilty of attempted murder. On Monday, the 61-year-old was convicted over the 14 January ...

Jonathan Peter Brooks was arrested on the day of the stabbing and appeared in court days later - but has only just been convicted More than four years after he stabbed his colleague, plastic ...

HONG KONG -- Economists focused on China raised their annual growth forecast for the country due to stronger first-quarter exports driven by accelerated orders, but the projection remains below ...

Elon Musk’s luxury electric vehicle manufacturer wants to build a factory on contaminated council land in Adelaide’s south – creating “significant” financial benefits. In a letter to ...

Get Instant Summarized Text (Gist) A clinical trial demonstrated that cord blood-derived natural killer (NK) cells pre-complexed with the bispecific antibody AFM13 showed high efficacy in treating ...

NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma Phase I trial demonstrates AFM13-NK cells are safe and highly effective in heavily pretreated ...